James Rigell
Psychiatry · Knoxville, TNNPI 1255657789
Payments from drug & device makers
Across 376 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$914
- Lundbeck LLC$617
- Otsuka America Pharmaceutical, Inc.$590
- Neurocrine Biosciences, Inc.$585
- AbbVie$567
- Takeda Pharmaceuticals U.S.A., Inc.$370
- plus $3K from 24 others
What the payments were for
- Food & beverage$6,05797%
- Education$2003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 49 | $914 |
| Lundbeck LLC | 45 | $617 |
| Otsuka America Pharmaceutical, Inc. | 41 | $590 |
| Neurocrine Biosciences, Inc. | 33 | $585 |
| AbbVie(2 entities) | 36 | $567 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $370 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $358 |
| Alkermes, Inc. | 19 | $346 |
| Sunovion Pharmaceuticals Inc. | 19 | $255 |
| Vanda Pharmaceuticals Inc. | 12 | $221 |
| Axsome Therapeutics, Inc. | 11 | $220 |
| Neos Therapeutics, LP | 7 | $124 |
| Avanir Pharmaceuticals, Inc. | 8 | $118 |
| Corium, LLC | 6 | $116 |
| Tris Pharma Inc | 6 | $114 |
| Supernus Pharmaceuticals, Inc. | 5 | $103 |
| Johnson & Johnson | 5 | $96 |
| Ironshore Pharmaceuticals Inc. | 5 | $90 |
| Idorsia Pharmaceuticals US Inc | 4 | $77 |
| Acadia Pharmaceuticals Inc | 4 | $62 |
| Bausch Health US, LLC | 4 | $60 |
| E.r. Squibb & Sons, L.L.C. | 3 | $51 |
| Almatica Pharma LLC | 2 | $38 |
| Adlon Therapeutics L.p. | 2 | $33 |
| Eisai Inc. | 2 | $30 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Shire North American Group Inc | 2 | $25 |
| Merck | 1 | $17 |
| Neuronetics, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
How this compares
$6,257 in reported general payments places this provider in the 85th percentile of 503 psychiatry providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 20 | $33,687 |
| VraylarCariprazine Hcl | 12 | $19,467 |
| Clozapine | 121 | $13,567 |
| TrintellixVortioxetine Hydrobromide | 16 | $11,881 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $5,233 |
| QuviviqDaridorexant Hcl | 11 | $5,100 |
| Mirtazapine | 64 | $2,493 |
| Trazodone Hcl | 126 | $2,252 |
| Quetiapine Fumarate | 108 | $2,218 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $2,077 |
| Bupropion XlBupropion Hcl | 71 | $1,741 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 22 | $1,723 |
| Duloxetine Hcl | 69 | $1,536 |
| Lamotrigine | 92 | $1,435 |
| Methylphenidate Hcl | 40 | $1,328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $590 | $33,68720 claims |
| AbbVieVraylar | $567 | $19,46712 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $370 | $17,11430 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $77 | $5,10011 claims |
| Almatica Pharma LLCSertraline Hcl | $38 | $1,05799 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 503 psychiatry providers in Tennessee.
Other psychiatry in Knoxville
- Karthi NamasivayamKnoxville$225K
- Lane CookKnoxville$53K
- Richard GibsonKnoxville$32K
- Kelley WalkerKnoxville$17K
- Sharon BurnsideKnoxville$16K
- James KennedyKnoxville$15K
- Bryan WestKnoxville$15K
- Kris HouserKnoxville$14K
- Charles MayKnoxville$9K
- Rakesh AminNashville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.